Iatrogenic Kaposi's sarcoma in a myelofibrosis patient treated with ruxolitinib: Case-report, literature review, and French pharmacovigilance data

Am J Hematol. 2022 Jan 1;97(1):E31-E34. doi: 10.1002/ajh.26398. Epub 2021 Nov 9.

¹ Department of Internal Medicine, Infectious Diseases, and Clinical Immunology, Reims University Hospital, Reims, France.
² Department of Virology, Hôpital Pitié Salpêtrière, Assistance Publique des Hôpitaux de Paris, Paris, France.
³ Department of Hematology, Reims University Hospital, Reims, France.
⁴ Department of Virology, Reims University Hospital, Reims, France.
⁵ Department of Dermatology, Reims University Hospital, Reims, France.
⁶ Department of Dermatology, Hôpital Saint Louis, Assistance Publique des Hôpitaux de Paris, Paris, France.
⁷ Regional Centre for Pharmacovigilance and Pharmacoepidemiology, Reims University Hospital, Reims, France.
⁸ University of Reims Champagne-Ardenne, Reims, France.

No abstract available

Publication types